Coloplast As Stock Beta
CBHD Stock | 112.25 0.85 0.76% |
Coloplast AS fundamentals help investors to digest information that contributes to Coloplast's financial success or failures. It also enables traders to predict the movement of Coloplast Stock. The fundamental analysis module provides a way to measure Coloplast's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Coloplast stock.
Coloplast |
Coloplast AS Company Beta Analysis
Coloplast's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, Coloplast AS has a Beta of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Healthcare Equipment & Supplies (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
All Next | Launch Module |
Coloplast Fundamentals
Return On Equity | 80.33 | |||
Current Valuation | 27.36 B | |||
Price To Book | 21.45 X | |||
Price To Sales | 7.90 X | |||
Revenue | 22.58 B | |||
EBITDA | 7.23 B | |||
Net Income | 6.44 B | |||
Total Debt | 16.36 B | |||
Cash Flow From Operations | 5.1 B | |||
Price To Earnings To Growth | 3.24 X | |||
Market Capitalization | 22.73 B | |||
Total Asset | 34.96 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.12 % | |||
Net Asset | 34.96 B | |||
Last Dividend Paid | 1.2 |
About Coloplast Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Coloplast AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coloplast using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coloplast AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.